{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:32:50Z","timestamp":1790004770018,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:00:00Z","timestamp":1510185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:00:00Z","timestamp":1510185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    There are presently no reliable ways to quantify endocrine cell mass (ECM)\n                    <jats:italic>in vivo<\/jats:italic>\n                    , which prevents an accurate understanding of the progressive beta cell loss in diabetes or following islet transplantation. To address this unmet need, we coupled RNA sequencing of human pancreatic islets to a systems biology approach to identify new biomarkers of the endocrine pancreas. Dipeptidyl-Peptidase 6 (DPP6) was identified as a target whose mRNA expression is at least 25-fold higher in human pancreatic islets as compared to surrounding tissues and is not changed by proinflammatory cytokines. At the protein level, DPP6 localizes only in beta and alpha cells within the pancreas. We next generated a high-affinity camelid single-domain antibody (nanobody) targeting human DPP6. The nanobody was radiolabelled and\n                    <jats:italic>in vivo<\/jats:italic>\n                    SPECT\/CT imaging and biodistribution studies were performed in immunodeficient mice that were either transplanted with DPP6-expressing Kelly neuroblastoma cells or insulin-producing human EndoC-\u03b2H1 cells. The human DPP6-expressing cells were clearly visualized in both models. In conclusion, we have identified a novel beta and alpha cell biomarker and developed a tracer for\n                    <jats:italic>in vivo<\/jats:italic>\n                    imaging of human insulin secreting cells. This provides a useful tool to non-invasively follow up intramuscularly implanted insulin secreting cells.\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-15417-2","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T10:16:47Z","timestamp":1509704207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic endocrine cells"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7581-121X","authenticated-orcid":false,"given":"Alexander","family":"Balhuizen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2896-3549","authenticated-orcid":false,"given":"Sam","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Mathijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Valery","family":"Turatsinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7254-2269","authenticated-orcid":false,"given":"St\u00e9phane","family":"Demine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olatz","family":"Villate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Millard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Egrise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Capito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Scharfmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"In\u2019t Veld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Muyldermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Lahoutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bouwens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2453-5889","authenticated-orcid":false,"given":"Decio L.","family":"Eizirik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Devoogdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"key":"15417_CR1","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1210\/jc.2012-1206","volume":"97","author":"BE Gregg","year":"2012","unstructured":"Gregg, B. E. et al. Formation of a human beta-cell population within pancreatic islets is set early in life. J Clin Endocrinol Metab \n                           97, 3197\u20133206, https:\/\/doi.org\/10.1210\/jc.2012-1206 (2012).","journal-title":"J Clin Endocrinol Metab"},{"key":"15417_CR2","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2337\/db15-0779","volume":"65","author":"M Campbell-Thompson","year":"2016","unstructured":"Campbell-Thompson, M. et al. Insulitis and beta-cell mass in the natural history of type 1 diabetes. Diabetes \n                           65, 719\u2013731, https:\/\/doi.org\/10.2337\/db15-0779 (2016).","journal-title":"Diabetes"},{"key":"15417_CR3","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00125-012-2491-7","volume":"55","author":"K Andralojc","year":"2012","unstructured":"Andralojc, K. et al. Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis. Diabetologia \n                           55, 1247\u20131257, https:\/\/doi.org\/10.1007\/s00125-012-2491-7 (2012).","journal-title":"Diabetologia"},{"key":"15417_CR4","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.2337\/db13-1877","volume":"63","author":"O Eriksson","year":"2014","unstructured":"Eriksson, O. et al. Positron emission tomography ligand [11C]5-hydroxy-tryptophan can be used as a surrogate marker for the human endocrine pancreas. Diabetes \n                           63, 3428\u20133437, https:\/\/doi.org\/10.2337\/db13-1877 (2014).","journal-title":"Diabetes"},{"key":"15417_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.tem.2014.02.002","volume":"25","author":"M Gotthardt","year":"2014","unstructured":"Gotthardt, M., Eizirik, D. L., Cnop, M. & Brom, M. Beta cell imaging - a key tool in optimized diabetes prevention and treatment. Trends in endocrinology and metabolism: TEM \n                           25, 375\u2013377, https:\/\/doi.org\/10.1016\/j.tem.2014.02.002 (2014).","journal-title":"Trends in endocrinology and metabolism: TEM"},{"key":"15417_CR6","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1210\/jc.2015-2860","volume":"101","author":"F Cinti","year":"2016","unstructured":"Cinti, F. et al. Evidence of beta-cell dedifferentiation in human type 2 diabetes. J Clin Endocrinol Metab \n                           101, 1044\u20131054, https:\/\/doi.org\/10.1210\/jc.2015-2860 (2016).","journal-title":"J Clin Endocrinol Metab"},{"key":"15417_CR7","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1210\/jc.2016-1350","volume":"101","author":"AS Md Moin","year":"2016","unstructured":"Md Moin, A. S. et al. Increased hormone-negative endocrine cells in the pancreas in type 1 diabetes. J Clin Endocrinol Metab \n                           101, 3487\u20133496, https:\/\/doi.org\/10.1210\/jc.2016-1350 (2016).","journal-title":"J Clin Endocrinol Metab"},{"key":"15417_CR8","doi-asserted-by":"publisher","first-page":"e1003934","DOI":"10.1371\/journal.pgen.1003934","volume":"9","author":"M Courtney","year":"2013","unstructured":"Courtney, M. et al. The inactivation of Arx in pancreatic alpha-cells triggers their neogenesis and conversion into functional beta-like cells. PLoS genetics \n                           9, e1003934, https:\/\/doi.org\/10.1371\/journal.pgen.1003934 (2013).","journal-title":"PLoS genetics"},{"key":"15417_CR9","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1089\/dia.2004.6.652","volume":"6","author":"IR Sweet","year":"2004","unstructured":"Sweet, I. R., Cook, D. L., Lernmark, A., Greenbaum, C. J. & Krohn, K. A. Non-invasive imaging of beta cell mass: a quantitative analysis. Diabetes Technol Ther \n                           6, 652\u2013659, https:\/\/doi.org\/10.1089\/dia.2004.6.652 (2004).","journal-title":"Diabetes Technol Ther"},{"key":"15417_CR10","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.2174\/138161210791164126","volume":"16","author":"M Brom","year":"2010","unstructured":"Brom, M., Andraojc, K., Oyen, J. G., Boerman, W. C. O. & Gotthardt, M. Development of radiotracers for the determination of the beta-cell mass in vivo. Current Pharmaceutical Design \n                           16, 1561\u20131567, https:\/\/doi.org\/10.2174\/138161210791164126 (2010).","journal-title":"Current Pharmaceutical Design"},{"key":"15417_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.addr.2010.09.015","volume":"63","author":"CM Gomes","year":"2011","unstructured":"Gomes, C. M., Abrunhosa, A. J., Ramos, P. & Pauwels, E. K. Molecular imaging with SPECT as a tool for drug development. Adv Drug Deliv Rev \n                           63, 547\u2013554, https:\/\/doi.org\/10.1016\/j.addr.2010.09.015 (2011).","journal-title":"Adv Drug Deliv Rev"},{"key":"15417_CR12","doi-asserted-by":"publisher","first-page":"e1002552","DOI":"10.1371\/journal.pgen.1002552","volume":"8","author":"DL Eizirik","year":"2012","unstructured":"Eizirik, D. L. et al. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS genetics \n                           8, e1002552, https:\/\/doi.org\/10.1371\/journal.pgen.1002552 (2012).","journal-title":"PLoS genetics"},{"key":"15417_CR13","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s00125-010-1714-z","volume":"53","author":"D Flamez","year":"2010","unstructured":"Flamez, D. et al. A genomic-based approach identifies FXYD domain containing ion transport regulator 2 (FXYD2)gammaa as a pancreatic beta cell-specific biomarker. Diabetologia \n                           53, 1372\u20131383, https:\/\/doi.org\/10.1007\/s00125-010-1714-z (2010).","journal-title":"Diabetologia"},{"key":"15417_CR14","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2217\/nnm.13.86","volume":"8","author":"G Hassanzadeh-Ghassabeh","year":"2013","unstructured":"Hassanzadeh-Ghassabeh, G., Devoogdt, N., De Pauw, P., Vincke, C. & Muyldermans, S. Nanobodies and their potential applications. Nanomedicine (Lond) \n                           8, 1013\u20131026, https:\/\/doi.org\/10.2217\/nnm.13.86 (2013).","journal-title":"Nanomedicine (Lond)"},{"key":"15417_CR15","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1517\/14712598.2013.800478","volume":"13","author":"J De Vos","year":"2013","unstructured":"De Vos, J., Devoogdt, N., Lahoutte, T. & Muyldermans, S. Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target. Expert Opin Biol Ther \n                           13, 1149\u20131160, https:\/\/doi.org\/10.1517\/14712598.2013.800478 (2013).","journal-title":"Expert Opin Biol Ther"},{"key":"15417_CR16","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.2967\/jnumed.115.156828","volume":"56","author":"A Blykers","year":"2015","unstructured":"Blykers, A. et al. PET imaging of macrophage mannose receptor-expressing macrophages in tumor stroma using 18F-radiolabeled camelid single-domain antibody fragments. J Nucl Med \n                           56, 1265\u20131271, https:\/\/doi.org\/10.2967\/jnumed.115.156828 (2015).","journal-title":"J Nucl Med"},{"key":"15417_CR17","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1096\/fj.10-180331","volume":"25","author":"I Vaneycken","year":"2011","unstructured":"Vaneycken, I. et al. Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer. FASEB journal: official publication of the Federation of American Societies for Experimental Biology \n                           25, 2433\u20132446, https:\/\/doi.org\/10.1096\/fj.10-180331 (2011).","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"15417_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10321","volume":"7","author":"CL Scott","year":"2016","unstructured":"Scott, C. L. et al. Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells. Nat Commun \n                           7, 10321, https:\/\/doi.org\/10.1038\/ncomms10321 (2016).","journal-title":"Nat Commun"},{"key":"15417_CR19","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2967\/jnumed.109.070078","volume":"51","author":"K De Groeve","year":"2010","unstructured":"De Groeve, K. et al. Nanobodies as tools for in vivo imaging of specific immune cell types. J Nucl Med \n                           51, 782\u2013789, https:\/\/doi.org\/10.2967\/jnumed.109.070078 (2010).","journal-title":"J Nucl Med"},{"key":"15417_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1161\/CIRCRESAHA.112.265140","volume":"110","author":"A Broisat","year":"2012","unstructured":"Broisat, A. et al. Nanobodies targeting mouse\/human VCAM1 for the nuclear imaging of atherosclerotic lesions. Circ Res \n                           110, 927\u2013937, https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.265140 (2012).","journal-title":"Circ Res"},{"key":"15417_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2967\/jnumed.115.162024","volume":"57","author":"M Keyaerts","year":"2016","unstructured":"Keyaerts, M. et al. Phase I study of 68Ga-HER2-Nanobody for PET\/CT assessment of HER2 expression in breast carcinoma. J Nucl Med \n                           57, 27\u201333, https:\/\/doi.org\/10.2967\/jnumed.115.162024 (2016).","journal-title":"J Nucl Med"},{"key":"15417_CR22","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.2337\/db13-1383","volume":"63","author":"M Cnop","year":"2014","unstructured":"Cnop, M. et al. RNA sequencing identifies dysregulation of the human pancreatic islet transcriptome by the saturated fatty acid palmitate. Diabetes \n                           63, 1978\u20131993, https:\/\/doi.org\/10.2337\/db13-1383 (2014).","journal-title":"Diabetes"},{"key":"15417_CR23","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00125-010-1707-y","volume":"53","author":"M Igoillo-Esteve","year":"2010","unstructured":"Igoillo-Esteve, M. et al. Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia \n                           53, 1395\u20131405, https:\/\/doi.org\/10.1007\/s00125-010-1707-y (2010).","journal-title":"Diabetologia"},{"key":"15417_CR24","doi-asserted-by":"publisher","first-page":"e11499","DOI":"10.1371\/journal.pone.0011499","volume":"5","author":"L Marselli","year":"2010","unstructured":"Marselli, L. et al. Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. PloS one \n                           5, e11499, https:\/\/doi.org\/10.1371\/journal.pone.0011499 (2010).","journal-title":"PloS one"},{"key":"15417_CR25","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.2337\/db15-0039","volume":"64","author":"DM Blodgett","year":"2015","unstructured":"Blodgett, D. M. et al. Novel observations from next-generation RNA sequencing of highly purified human adult and fetal islet cell subsets. Diabetes \n                           64, 3172\u20133181, https:\/\/doi.org\/10.2337\/db15-0039 (2015).","journal-title":"Diabetes"},{"key":"15417_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cmet.2016.08.020","volume":"24","author":"A Segerstolpe","year":"2016","unstructured":"Segerstolpe, A. et al. Single-cell transcriptome profiling of human pancreatic islets in health and type 2 Diabetes. Cell Metab \n                           24, 593\u2013607, https:\/\/doi.org\/10.1016\/j.cmet.2016.08.020 (2016).","journal-title":"Cell Metab"},{"key":"15417_CR27","doi-asserted-by":"publisher","first-page":"D746","DOI":"10.1093\/nar\/gkv1045","volume":"44","author":"R Petryszak","year":"2016","unstructured":"Petryszak, R. et al. Expression Atlas update-an integrated database of gene and protein expression in humans, animals and plants. Nucleic Acids Res \n                           44, D746\u2013752, https:\/\/doi.org\/10.1093\/nar\/gkv1045 (2016).","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 1","key":"15417_CR28","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.2337\/diabetes.50.2007.S30","volume":"50","author":"C Bernard-Kargar","year":"2001","unstructured":"Bernard-Kargar, C. & Ktorza, A. Endocrine pancreas plasticity under physiological and pathological conditions. Diabetes \n                           50(Suppl 1), S30\u201335, https:\/\/doi.org\/10.2337\/diabetes.50.2007.S30 (2001).","journal-title":"Diabetes"},{"key":"15417_CR29","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/nature08894","volume":"464","author":"F Thorel","year":"2010","unstructured":"Thorel, F. et al. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature \n                           464, 1149\u20131154, https:\/\/doi.org\/10.1038\/nature08894 (2010).","journal-title":"Nature"},{"key":"15417_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.devcel.2013.05.018","volume":"26","author":"K Al-Hasani","year":"2013","unstructured":"Al-Hasani, K. et al. Adult duct-lining cells can reprogram into beta-like cells able to counter repeated cycles of toxin-induced diabetes. Developmental cell \n                           26, 86\u2013100, https:\/\/doi.org\/10.1016\/j.devcel.2013.05.018 (2013).","journal-title":"Developmental cell"},{"key":"15417_CR31","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.2337\/db12-1001","volume":"62","author":"HS Spijker","year":"2013","unstructured":"Spijker, H. S. et al. Conversion of mature human beta-cells into glucagon-producing alpha-cells. Diabetes \n                           62, 2471\u20132480, https:\/\/doi.org\/10.2337\/db12-1001 (2013).","journal-title":"Diabetes"},{"key":"15417_CR32","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.2337\/db16-0222","volume":"65","author":"O Eriksson","year":"2016","unstructured":"Eriksson, O. et al. Positron emission tomography to assess the outcome of intraportal islet transplantation. Diabetes \n                           65, 2482\u20132489, https:\/\/doi.org\/10.2337\/db16-0222 (2016).","journal-title":"Diabetes"},{"key":"15417_CR33","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1016\/j.jprot.2012.03.008","volume":"75","author":"C Lindskog","year":"2012","unstructured":"Lindskog, C. et al. Novel pancreatic beta cell-specific proteins: antibody-based proteomics for identification of new biomarker candidates. J Proteomics \n                           75, 2611\u20132620, https:\/\/doi.org\/10.1016\/j.jprot.2012.03.008 (2012).","journal-title":"J Proteomics"},{"key":"15417_CR34","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.cmet.2005.11.001","volume":"2","author":"P Akpinar","year":"2005","unstructured":"Akpinar, P., Kuwajima, S., Krutzfeldt, J. & Stoffel, M. Tmem27: a cleaved and shed plasma membrane protein that stimulates pancreatic beta cell proliferation. Cell Metab \n                           2, 385\u2013397, https:\/\/doi.org\/10.1016\/j.cmet.2005.11.001 (2005).","journal-title":"Cell Metab"},{"key":"15417_CR35","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.2337\/db09-0658","volume":"58","author":"S Ueberberg","year":"2009","unstructured":"Ueberberg, S. et al. Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic beta- or alpha-cells in vivo. Diabetes \n                           58, 2324\u20132334, https:\/\/doi.org\/10.2337\/db09-0658 (2009).","journal-title":"Diabetes"},{"key":"15417_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-11-684","volume":"11","author":"D Klevebring","year":"2010","unstructured":"Klevebring, D. et al. Analysis of transcript and protein overlap in a human osteosarcoma cell line. BMC Genomics \n                           11, 684, https:\/\/doi.org\/10.1186\/1471-2164-11-684 (2010).","journal-title":"BMC Genomics"},{"key":"15417_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2006.03.106","volume":"1094","author":"MS Nadal","year":"2006","unstructured":"Nadal, M. S., Amarillo, Y., Vega-Saenz de Miera, E. & Rudy, B. Differential characterization of three alternative spliced isoforms of DPPX. Brain Res \n                           1094, 1\u201312, https:\/\/doi.org\/10.1016\/j.brainres.2006.03.106 (2006).","journal-title":"Brain Res"},{"key":"15417_CR38","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1006\/geno.2000.6117","volume":"64","author":"D Isbrandt","year":"2000","unstructured":"Isbrandt, D. et al. Gene structures and expression profiles of three human KCND (Kv4) potassium channels mediating A-type currents I(TO) and I(SA). Genomics \n                           64, 144\u2013154, https:\/\/doi.org\/10.1006\/geno.2000.6117 (2000).","journal-title":"Genomics"},{"key":"15417_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/neuro.02.008.2008","volume":"1","author":"BD Clark","year":"2008","unstructured":"Clark, B. D. et al. DPP6 localization in brain supports function as a Kv4 channel associated protein. Front Mol Neurosci \n                           1, 8, https:\/\/doi.org\/10.3389\/neuro.02.008.2008 (2008).","journal-title":"Front Mol Neurosci"},{"key":"15417_CR40","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s11307-014-0731-6","volume":"16","author":"J De Vos","year":"2014","unstructured":"De Vos, J. et al. Specific targeting of atherosclerotic plaques in ApoE(\u2212\/\u2212) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1. Mol Imaging Biol \n                           16, 690\u2013698, https:\/\/doi.org\/10.1007\/s11307-014-0731-6 (2014).","journal-title":"Mol Imaging Biol"},{"key":"15417_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/cmmi.408","volume":"6","author":"LO Gainkam","year":"2011","unstructured":"Gainkam, L. O. et al. Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice. Contrast Media Mol Imaging \n                           6, 85\u201392, https:\/\/doi.org\/10.1002\/cmmi.408 (2011).","journal-title":"Contrast Media Mol Imaging"},{"key":"15417_CR42","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.2337\/db10-0205","volume":"59","author":"G Christoffersson","year":"2010","unstructured":"Christoffersson, G. et al. Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets. Diabetes \n                           59, 2569\u20132578, https:\/\/doi.org\/10.2337\/db10-0205 (2010).","journal-title":"Diabetes"},{"key":"15417_CR43","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2337\/diabetes.54.3.727","volume":"54","author":"S Del Guerra","year":"2005","unstructured":"Del Guerra, S. et al. Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes \n                           54, 727\u2013735, https:\/\/doi.org\/10.2337\/diabetes.54.3.727 (2005).","journal-title":"Diabetes"},{"key":"15417_CR44","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1172\/JCI58447","volume":"121","author":"P Ravassard","year":"2011","unstructured":"Ravassard, P. et al. A genetically engineered human pancreatic beta cell line exhibiting glucose-inducible insulin secretion. The Journal of clinical investigation \n                           121, 3589\u20133597, https:\/\/doi.org\/10.1172\/JCI58447 (2011).","journal-title":"The Journal of clinical investigation"},{"key":"15417_CR45","doi-asserted-by":"publisher","first-page":"20677","DOI":"10.1074\/jbc.M114.568808","volume":"289","author":"F Brozzi","year":"2014","unstructured":"Brozzi, F. et al. A combined \u201comics\u201d approach identifies N-Myc interactor as a novel cytokine-induced regulator of IRE1 protein and c-Jun N-terminal kinase in pancreatic beta cells. J Biol Chem \n                           289, 20677\u201320693, https:\/\/doi.org\/10.1074\/jbc.M114.568808 (2014).","journal-title":"J Biol Chem"},{"key":"15417_CR46","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1387\/ijdb.052004jm","volume":"49","author":"JK Mfopou","year":"2005","unstructured":"Mfopou, J. K., Willems, E., Leyns, L. & Bouwens, L. Expression of regulatory genes for pancreas development during murine embryonic stem cell differentiation. Int J Dev Biol \n                           49, 915\u2013922, https:\/\/doi.org\/10.1387\/ijdb.052004jm (2005).","journal-title":"Int J Dev Biol"},{"key":"15417_CR47","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.2337\/db13-0554","volume":"62","author":"C Capito","year":"2013","unstructured":"Capito, C. et al. Mouse muscle as an ectopic permissive site for human pancreatic development. Diabetes \n                           62, 3479\u20133487, https:\/\/doi.org\/10.2337\/db13-0554 (2013).","journal-title":"Diabetes"},{"key":"15417_CR48","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jmb.2005.07.038","volume":"352","author":"D Saerens","year":"2005","unstructured":"Saerens, D. et al. Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies. J Mol Biol \n                           352, 597\u2013607, https:\/\/doi.org\/10.1016\/j.jmb.2005.07.038 (2005).","journal-title":"J Mol Biol"},{"key":"15417_CR49","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nbt.2747","volume":"32","author":"L Baeyens","year":"2014","unstructured":"Baeyens, L. et al. Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice. Nat Biotechnol \n                           32, 76\u201383, https:\/\/doi.org\/10.1038\/nbt.2747 (2014).","journal-title":"Nat Biotechnol"},{"key":"15417_CR50","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1021\/bc500111t","volume":"25","author":"S Massa","year":"2014","unstructured":"Massa, S. et al. Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging. Bioconjug Chem \n                           25, 979\u2013988, https:\/\/doi.org\/10.1021\/bc500111t (2014).","journal-title":"Bioconjug Chem"},{"key":"15417_CR51","unstructured":"Xavier, C. et al. In Single Domain Antibodies: Methods and Protocols (eds Dirk Saerens & Serge Muyldermans) 485\u2013490 (Humana Press, 2012)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15417-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15417-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15417-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T08:24:11Z","timestamp":1671783851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15417-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["15417"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-15417-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,9]]},"assertion":[{"value":"2 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.B., I. Ma., S.M., L.B., N.D. and D.L.E. have submitted a patent based on the use of DPP6 and the nanobodies targeting it for pancreatic islet cell imaging. T.L., J.D. and N.D. are cofounders and consultants of the biotech company Camel-IDS. T.L. and N.D. have received funding from Boehringer-Ingelheim, Complix and 121BIO. T.L. and N.D. hold patents on Nanobody imaging and therapy.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15130"}}